Editas Medicine is a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Their goal is to discover, develop, manufacture, and commercialize transformative medicines for a range of serious diseases, including eye diseases, blood diseases, and cancer. 

Biotechnology

Editas Medicine

Editas Medicine's headquarters in Cambridge, MA, United States

Gilmore O’Neill

Linda C. Burkly

Gregory Whitehead

Greg Whitehead

Zatcha Montes

Frank Panaccio

Vice President, Clinical Development

Preethi Bapna

Tom Love

Jacqueline Caster

Amy Parison

George Church

Process Engineer, Formulation Development

Damien Grierson

Jessica Hopfield

David Scadden

Bernadette Connaughton

Andrew Hirsch

This department focuses on conducting advanced research and development in scientific fields to drive innovation and discovery.

Scientific Research

The Leadership Team at Editas Medicine drives the strategic direction and operational excellence of the company, overseeing critical functions such as research and development, legal compliance, commercial strategy, and clinical operations. This diverse group of executives collaborates to advance innovative genome editing therapies, ensure regulatory compliance, and foster partnerships, all while focusing on delivering transformative medicines for patients with genetically-defined diseases.

Leadership Team

The Clinical Development and Trials team at Editas Medicine is responsible for designing, implementing, and overseeing clinical trials that evaluate the safety and efficacy of innovative gene-editing therapies. This team collaborates closely with various stakeholders, including regulatory agencies and patient advocacy groups, to ensure compliance and facilitate patient recruitment, while also managing clinical data and translating research findings into actionable insights for future treatment developments. Their ultimate goal is to bring transformative medicines to patients with genetically-defined diseases.

Clinical Development and Trials

This department ensures the quality and reliability of products and services through systematic testing and evaluation.

Quality Assurance

This department manages financial planning, analysis, and corporate communications initiatives.

Finance and Communications

This department oversees the planning, implementation, and management of clinical operations to ensure efficient and effective clinical trials.

Editas Medicine

Org chart

Board & advisors

Teams

Scientific Research

Leadership Team

Clinical Development and Trials

Quality Assurance

Finance and Communications

Clinical Operations

Offices

Editas Medicine

Org chart

Board & advisors

Teams

Scientific Research

Leadership Team

Clinical Development and Trials

Quality Assurance

Finance and Communications

Clinical Operations

Offices

Related companies